Pfizer, Moderna and COVID-19

Zacks Investment Research on MSN11m
Here's Why Moderna Stock Soared 16% on Wednesday
Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on ...
Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...
After finding support at $30, Moderna (MRNA) added nearly $5.00 to close at $35.21. The firm participated in TD Cowen’s ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market.
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...